Skip to main content

ARCA Biopharma: COVID Treatment Phase 2B Data Coming In 2nd Quarter

While extremely speculative, this biotech may be worth a shot for an explosive move, if the data is positive.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.